UWO23 Cells

The UWO23 (HPV33) cell line is derived from the tumor cells of a male patient with oral tongue cancer and is particularly notable for its expression of Human Papillomavirus type 33 (HPV33). This specific feature of UWO23 makes it a critical resource for research into the oncogenic roles of HPV in head and neck squamous cell carcinoma (HNSCC). The presence of HPV33 in these cells provides a unique opportunity to explore how this virus influences the carcinogenesis process, particularly in the context of oral and oropharyngeal regions.

Research utilizing the UWO23 cell line focuses on uncovering the molecular and genetic interactions driven by HPV33 that lead to the development and progression of cancer. This includes studying alterations in cell cycle regulation, apoptosis resistance, and changes in cellular adhesion and motility, all of which are crucial for understanding tumor behavior and metastasis. Additionally, the UWO23 cell line is instrumental in the evaluation of new pharmacological treatments and potential diagnostic biomarkers for HPV-related cancers. By elucidating the pathways through which HPV33 contributes to malignancy, researchers can develop targeted therapies that might improve therapeutic outcomes for patients suffering from HPV-associated head and neck cancers.